Article Details

Abivax suspends trading of its shares until the publication of ABX464 Phase 2b results in ulcerative ...

Retrieved on: 2021-05-24 06:45:00

Tags for this article:

Click the tags to see associated articles and topics

Abivax suspends trading of its shares until the publication of ABX464 Phase 2b results in ulcerative .... View article details on hiswai:

Excerpt

... a clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral ...

Article found on: www.pharmiweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up